My Cart [ 0 ]
New Products
New Services
Promotions
News
Home > Research-Grade Biosimilars
Recombinant research-grade biosimilars (RUO) have the same protein sequences of therapeutic grade biologics (proteins and antibodies) with lower prices (starting from $30/mg for bulk order). For research use only.
    104 Research-Grade Biosimilars Products
  • C031P: Nimotuzumab Biosimilar, EGFR Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade nimotuzumab biosimilar specifically binds to the human epidermal growth factor receptor (EGFR).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by nimotuzumab.

  • C075P: Etanercept Biosimilar

    Recombinant protein composed of the soluble TNF receptor 2 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1).
    Specificity/Sensitivity: The etanercept biosimilar protein specifically binds to the human TNF alpha.
    Applications: Functional assays, and those assays for studying biological pathways affected by etanercept.

  • C037P: Tremelimumab Biosimilar, CTLA-4 monoclonal antibody

    Recombinant Chimeric IgG2 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade tremelimumab biosimilar specifically binds to the human protein receptor CD152 / CTLA4.
    Applications: ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in vivo assays for studying biological pathways affected by tremelimumab.

  • C055P: Natalizumab Biosimilar, Integrin alpha 4 Monoclonal Antibody

    Recombinant Humanized IgG4 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade natalizumab biosimilar specifically binds to the human Integrin α4.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by natalizumab.

  • C053P: Mogamulizumab Biosimilar, CCR4 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade mogamulizumab biosimilar specifically binds to the human CC chemokine receptor 4 (CCR4).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by mogamulizumab.

  • C033P: Minretumomab Biosimilar, TAG-72 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade minretumomab biosimilar specifically binds to the human TAG-72 protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by minretumomab.

  • C051P: Matuzumab Biosimilar, EGFR Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade matuzumab biosimilar specifically binds to the human epidermal growth factor receptor (EGFR).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by matuzumab.

  • C068P: Isatuximab Biosimilar, CD38 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade isatuximab biosimilar specifically binds to the human CD38 proteins.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by isatuximab.

  • C048P: Galiximab Biosimilar, CD80 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade galiximab biosimilar specifically binds to the human CD80.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by galiximab.

  • C047P: Felvizumab Biosimilar, RSV Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade felvizumab biosimilar specifically binds to the human Respiratory Syncytial Virus.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by felvizumab.

See our Privacy Policy